Haleon plc (LON:HLN)

Market Cap	35.36B
Revenue (ttm)	11.24B
Net Income (ttm)	1.21B
Shares Out	9.05B
EPS (ttm)	0.13
PE Ratio	29.77
Forward PE	20.75
Dividend	0.06 (1.61%)
Ex-Dividend Date	n/a

Volume	19,023,490
Average Volume	19,295,674
Open	383.90
Previous Close	385.90
Day's Range	383.00 - 391.60
52-Week Range	308.37 - 400.65
Beta	0.22
RSI	58.89
Earnings Date	Feb 27, 2025

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 25,408
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HLN

Financial Performance

In 2023, Haleon's revenue was 11.30 billion, an increase of 4.09% compared to the previous year's 10.86 billion. Earnings were 1.05 billion, a decrease of -1.04%.